Full index of posts »
The Tumor-Infiltrating Lymphocytes (TILs) And Cancer Therapy $LBIO http://seekingalpha.com/a/1cujv Jun 20, 2014
Celator: A Unique Drug Ratio Technology Company For Cancer $CPXX http://seekingalpha.com/p/1r47t May 28, 2014
Applied DNA Sciences: An Unique Biotech Company Targeting The Anti-Counterfeiting Market $APDN http://seekingalpha.com/a/1bilr May 15, 2014
- innsbrooklad on The FDA Letter Won't Impact Atossa’S Business Much GrantHow about an apology. You said the FDA let...
- Herlina on GeoVax Is On Track To Advance Its HIV/AIDS Vaccine Programs In 2013 hello everyone, HIV CURE IS OUT BY PROPHET OLOR...
- jluscher on Arrowhead: There Is Still Room For Further Share Price Appreciation Thanks for the insight into how ARC-520 works.
- Grant Zeng, CFA on TKMR Is On Track To Advance TKM-Ebola Program sorry for being late responding to your questio...
- Grant Zeng, CFA on ATOS: Any Retreat In Share Price Should Provide A Good Entry Opportunity Sorry, I don't cover TROV.
- HJStebbins on TKMR Is On Track To Advance TKM-Ebola Program thnaks, a couple follow ups:so at 45k x ~2400 =...
- Advaxis (ADXS) Is On Track To Achieve 2012 Goals (4 Comments)
- TKMR Is On Track To Advance TKM-Ebola Program (4 Comments)
- ATOS: Any Retreat In Share Price Should Provide A Good Entry Opportunity (3 Comments)
- The FDA Letter Won't Impact Atossa’S Business Much (1 Comment)
- GeoVax Is On Track To Advance Its HIV/AIDS Vaccine Programs In 2013 (1 Comment)